The bill, authored by state Sen. Catherine Blakespear, D-Encinitas, was drafted in response to a chemical scare earlier this year at GKN Aerospace in Garden Grove, an incident that forced evacuation orders affecting roughly 50,000 Orange County residents. The proposal sought to scale back a broad exemption under the California Environmental Quality Act that currently applies to a wide range of advanced manufacturing operations, limiting the carve-out to facilities involved only in final-stage production.

In his veto message issued Friday, Newsom argued that Senate Bill 954 would have effectively gutted the exemption altogether rather than simply refining it. “Protecting communities and strengthening California’s advanced manufacturing economy are not mutually exclusive goals,” he wrote, adding that the exemption was intentionally designed to serve both purposes and deserves time to prove itself. If issues surface down the road, he said, lawmakers should pursue narrow fixes rather than dismantling the policy before it has a chance to work.

Blakespear said she was disappointed by the decision and intends to bring the issue back before the Legislature next year. She pointed again to the Garden Grove episode as evidence of the risks posed by unchecked exemptions.

“We should not have to wait for another emergency before recognizing that sweeping — and rushed — exemptions from environmental review need reasonable guardrails,” she said. “Protecting communities and workers is not an impediment to economic growth — it is part of responsible growth.”

The debate traces back to last year’s contentious overhaul of California’s signature environmental law, a rewrite Newsom personally pushed through by threatening to hold up state budget approval unless lawmakers agreed to the changes. Legislators ultimately went along with the plan but voiced unease over how sweeping the new manufacturing exemption turned out to be, covering everything from strip mines to renewable energy facilities.

Environmental advocates maintain that Blakespear’s bill wouldn’t have blocked manufacturing projects outright — it simply would have added safeguards for nearby residents. Kim Delfino, a lobbyist representing environmental justice organizations, said the veto undermines a basic principle of environmental law.

“It’s really unfortunate that we have to wait until something bad happens before we make an adjustment,” Delfino said. “A foundation of environmental law is the precautionary principle: that we try to protect instead of waiting for something bad to happen. This is flipping it on its head.”

Asha Sharma, deputy director of Sierra Club California, echoed that concern, saying the veto represents a missed chance to shield communities that are frequently asked to absorb the risks of industrial development without adequate protections or a voice in the process.

Industry groups, however, welcomed Newsom’s decision. Organizations including the Bay Area Council and the California Manufacturers & Technology Association had lobbied against the bill, warning it could hinder the state’s competitiveness in emerging industries.

Bay Area Council CEO Libby Schaaf praised the veto, saying advanced manufacturing is central to California’s economic future. “From autonomous vehicles and clean energy systems to revolutionary medical devices and digital technologies, advanced manufacturing is building the future and creating the good-paying, high-skilled jobs that California desperately needs,” she said.

Original source: CalMatters

The post Newsom Vetoes Bill Restricting Factories Near Homes, Schools, Siding With Industry appeared first on The Hemet & San Jacinto Chronicle.

From private companies to public, there are numerous ones out there to look at and consider.  Investment managers have built portfolios of cannabis companies that are stated to expand diversification and reduce risks.  Sectors of the economy expanding into Cannabis include medical, food and beverage, tobacco, security, transportation, processing, automation, real estate, chemical and fertilizer, and manufacturing. A new world has opened up and embraced Cannabis as a multi-billion-dollar industry to start. 

An investor can directly invest in a cannabis company that cultivates, manufactures, and sells its wares.  Another option is to indirectly invest in the industry through companies that support cannabis producers.  Mentioned earlier, this could be new plastic bags, or the RFID used to track-and-trace that states require.  There is a hub of businesses that are in the business but not in the business.  When building a position or selecting a company to invest in it is important to understand that you may already have exposure through an existing position.  For example, Constellation Brands (STZ), an alcohol company with operations worldwide that produces brands like Corona, Modelo, and Ballast Point, is in the business.  Constellation owns 38% of Canopy Growth, a Canadian Pot Producer.  The same is true for many companies.  It is hard for them not to push into a new high growth area.  After all there are two congressional bills moving through the Hill right now to allow cannabis companies to bank with FDIC institutions and to move it from a Class 1 to a Class 3 drug.  With the illegal becoming legal, a new opportunity has arisen and isn’t likely to go up in smoke.

Take GW Pharmaceuticals (GWPH), a British company known for its multiple sclerosis treatment product Nabiximols, which was the first natural cannabis plant derivative to gain market approval in every country, even ours.  Their latest drug treats pediatric seizures.  Breakthroughs are happening in every facet.   The key is to not jump into any company before you understand what you are buying their price movements. 

Concerns about the cost of cannabis and related products and where it is headed is a risk.  The cost will most likely be driven down and so may be margins as larger producers and market efficiencies occur.  This will force consolidations in the industry and sharp barriers to entry too.  What I have noticed is there is substantial volatility in pricing of these companies.  By being patient, you can pick up what you wish to buy on the dip and you shouldn’t have to wait long to get the opportunity. 

Pot’s passé and Cannabis is open for business.

Andrew F. Kotyuk, CIMA* is CEO and Principal of Alpha Wealth Management LLC

For questions or investment topics, please email me afkotyuk@alpha-wealth.com.

Visit www.hsjchronicle.com for your local news source.

The post CANNABUSINESS appeared first on The Hemet & San Jacinto Chronicle.